Lilly and Feds Disagree Over Whether 340B Case Is Ripe for Appeal

Drug maker Lilly and the federal government disagree over Lilly's 340B contract pharmacy appeal to U.S. Seventh Circuit Court of Appeals.

Drug manufacturer Lilly and the federal government disagree over whether a federal district judge’s recent decision in Lilly’s 340B contract pharmacy case is ripe for review.

Last month, the U.S. Seventh Circuit Court of Appeals questioned whether U.S. Senior

Read More »

Supreme Court May Upend Medicare DSH Calculation Formula, Which Would Impact 340B Stakeholders

Supreme Court Justices announced in a June 10 order that they’d review the U.S. Court of Appeals for the D.C. Circuit’s September 2023 decision in Advocate Christ Medical Center v. Becerra.

340B hospitals’ challenge to Medicare Part B drug reimbursement cuts was not the only case on the U.S. Supreme Court docket this week that could have a significant impact on the program.

On Monday, the justices heard the case of

Read More »

News Alert: U.S. Supreme Court Justices Question CMS’s Legal Basis for Slashing 340B Hospitals’ Drug Reimbursement

The U.S. Supreme Court heard arguments today about the legality of the nearly 30% Medicare Part B drug payment cut for 340B hospitals.

Several U.S. Supreme Court justices asked during a hearing today whether the Centers for Medicare & Medicaid Services (CMS) had statutory authority to single out 340B hospitals for a nearly 30% cut in Medicare Part B drug reimbursement beginning in

Read More »

340B Providers Take Center Stage Before U.S. Supreme Court Today

The U.S. Supreme Court is hearing arguments this morning in a lawsuit challenging CMS's nearly 30% cut in 340B hospitals' drug reimbursement.

The U.S. Supreme Court is hearing arguments this morning in a lawsuit challenging the nearly 30% cut since 2018 in what Medicare Part B pays hospitals for 340B-purchased physician administered drugs.

Arguments in American Hospital Association v. Becerra are due

Read More »

News Alert: Novo Nordisk Joins Sanofi in Appealing Court’s 340B Contract Pharmacy Decision

Novo Nordisk yesterday appealed a federal district judge’s Nov. 5 joint ruling in its and fellow manufacturer Sanofi’s 340B contract pharmacy lawsuits. Sanofi appealed earlier in the day.

Drug manufacturer Novo Nordisk late yesterday appealed a federal district judge’s Nov. 5 joint ruling in its and fellow manufacturer Sanofi’s 340B contract pharmacy lawsuits. Sanofi filed its appeal earlier yesterday.

Novo Nordisk’s notice of appeal, like Sanofi’s, is

Read More »

News Alert: Sanofi Is the Second Manufacturer to Appeal a 340B Contract Pharmacy Court Ruling

Drug manufacturer Sanofi is appealing a federal district judge’s Nov. 5 ruling in its 340B contract pharmacy lawsuit.

Drug manufacturer Sanofi today gave notice that it is appealing a federal district judge’s Nov. 5 orders and opinions in its 340B contract pharmacy lawsuit.

Sanofi’s one-sentence Nov. 19 notification to the federal government defendants and U.S. Chief District

Read More »

Appeals Court Raises Procedural Questions About Lilly’s 340B Contract Pharmacy Case

A federal appeals court is questioning whether a lower court's ruling in Lilly's 340B contract pharmacy suit is "ready for appellate review."

Drug manufacturer Lilly’s appeal of a federal district judge’s ruling late last month in the company’s 340B contract pharmacy lawsuit has hit a procedural snag.

In an unsigned pair of orders on Tuesday, the federal appeals court in Chicago questioned

Read More »

AstraZeneca and Feds Keep Sparring over 340B While Waiting for Judge to Rule

AstraZeneca and the federal government are awaiting the federal district court in Delaware's decision in the company’s 340B contract pharmacy lawsuit.

Drug manufacturer’s AstraZeneca and the federal government continue to joust in court as they await a crucial decision in the company’s 340B contract pharmacy lawsuit.

The two sides on Friday filed a joint status report in Astra’s lawsuit to

Read More »

Insulin and Diabetes Drug Makers Ask Judge to Dismiss 340B-Related Antitrust Charges

Insulin and diabetes drug manufacturers want a federal district judge to dismiss 340B-related antitrust changes against them.

U.S. manufacturers of insulin and diabetes-related treatments asked a federal judge on Friday to dismiss two health centers’ antitrust class action over the companies’ denials of 340B pricing when covered entities use contract pharmacies.

In a Nov. 11 joint

Read More »

In What Could be the First of Many Challenges, Lilly Appealing U.S. District Court’s 340B Contract Pharmacy Ruling

Lilly yesterday filed notice that it is appealing a federal district judge's decision in its 340B contract pharmacy lawsuit.

Drug manufacturer Eli Lilly late yesterday filed notice that it is appealing a federal district judge’s Oct. 29 ruling partially in Lilly’s favor and partially for the federal government on the legality of Lilly’s denials of 340B ceiling prices when

Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live